Tag: Investing

Read More

Johnson & Johnson requests FDA nod for Spravato as solo depression therapy

Johnson & Johnson (NYSE: JNJ) has asked U.S. regulators to approve its nasal spray Spravato as a standalone treatment for adults with treatment-resistant depression, the company announced Monday. The pharmaceutical giant is seeking to expand the use of Spravato, which is currently approved only in combination with oral antidepressants. Approval …

Read More

Tilray nabs first medical growers license in Germany under new laws

Tilray Brands Inc. (NASDAQ: TLRY) announced Monday that its German subsidiary has received the country’s first new cannabis cultivation license under recently updated regulations, paving a path for its expansion in Europe’s largest economy. The license, which was given to Tilray’s Aphria RX facility, allows cultivation and manufacture of “a …